AOR

The Archives of Ophthalmological Research aims to publish issues related to publish articles of the highest scientific and clinical value at an international level, and accepts articles on these topics. The target audience of the journal included specialists and physicians working in ophthalmology, and other health professionals interested in these fields.

EndNote Style
Index
Original Article
Evaluation of choroidal vascular structure in patients with retinal vein occlusion
Aims: To evaluate the posterior segment structures and choroidal vascularity of the eye in patients with retinal vein occlusion (RVO) using enhanced depth imaging optical coherence tomography (Edi-OCT).
Methods: Twenty-nine treatment-naïve patients with RVO (17 males, 12 females) were examined by EDI-OCT. Subfoveal choroid tickness and choroidal vascularity index (CVI) were used to compare the structural characteristics of the choroid with the eyes of twenty-nine age, and gender-matched controls. EDI-OCT images were binarised using ImageJ program.
Results: Best corrected visual acuity was significantly lower in the affected eyes compared to control group (p=<0.001). Central macular thickness, subfoveal choroidal thickness, choroid stromal area, and total choroid area were found to be significantly higher in the patient group (p=<0.05). CVI was significantly lower in the patient group and no significant difference was found between the groups in terms of intraocular pressure values (p>0.05).
Conclusion: RVO causes significant edema in the choroid stromal area without any change in the choroid lumen area. This structural changes in the choroid evaluated by EDI-OCT, a non-invasive examination, may be used in the diagnosis and follow-up of RVO.


1. Rogers S, McIntosh RL, Cheung N, et al.The prevalence of retinal veinocclusion: pooled data from population studies from the United States,Europe, Asia, and Australia.Ophthalmology2010;117:313-319.
2. Klein R, Moss SE, Meuer SM, Klein BE. The 15-year cumulativeincidence of retinal vein occlusion: the beaver dam eye study. ArchOphthalmol. 2008;126(4):513-518.
3. Mitchell P, Smith W, Chang A. Prevalence and associations of retinalvein occlusion in Australia. The blue mountains eye study. ArchOphthalmol. 1996;114(10):1243-1247.
4. Dodson PM, Galton DJ, Hamilton AM, Blach RK. Retinal veinocclusion and the prevalence of lipoprotein abnormalities. Br JOphthalmol. 1982;66(3):161-164.
5. Vannas S, Tarkkanen A. Retinal vein occlusion and glaucoma.Tonographic study of the incidence of glaucoma and of its prognosticsignificance. Br J Ophthalmol. 1960;44(10):583-589.
6. Rayess N, Rahimy E, Ying GS, et al. Baseline choroidal thickness as apredictor for treatment outcomes in central retinal vein occlusion. Am JOphthalmol. 2016;171:47-52.
7. Khodabandeh A, Shahraki K, Roohipoor R, et al. Quantitativemeasurement of vascular density and flow using optical coherencetomography angiography (OCTA) in patients with central retinalvein occlusion: Can OCTA help in distinguishing ischemic from non-ischemic type? Int J Retina Vitreous. 2018;27(4):47.
8. Mastropasqua R, Toto L, Di Antonio L, et al. Optical coherencetomography angiography microvascular findings in macular edema dueto central and branch retinal vein occlusions. Sci Rep. 2017;18(7):40763.
9. Du KF, Xu L, Shao L, et al. Subfoveal choroidal thickness in retinal veinocclusion. Ophthalmology. 2013;120(12):2749-2750.
10. Agrawal R, Gupta P, Tan KA, Cheung CM, Wong TY, Cheng CY.Choroidal vascularity index as a measure of vascular status of thechoroid: measurements in healthy eyes from a population-based study.Sci Rep. 2016; 12;6:21090.
11. Sharma A, D&rsquo;Amico DJ. Medical and surgical management of centralretinal vein occlusion. Int Ophthalmol Clin. 2004;44(1):1-16.
12. Grassi P, Naclerio C. Central retinal vein prethrombosis secondaryto retinal vasculitis: early detection and treatment. Middle East Afr JOphthalmol. 2020;20;27(2):131-133.
13. Schmidt-Erfurth U, Garcia-Arumi J, Gerendas BS, et al. Guidelines forthe management of retinal vein occlusion by the European Society ofRetina Specialists (EURETINA). Ophthalmologica. 2019;242(3):123-162.
14. Tsuiki E, Suzuma K, Ueki R, Maekawa Y, Kitaoka T. Enhanced depthimaging optical coherence tomography of the choroid in central retinalvein occlusion. Am J Ophthalmol. 2013;156(3):543-547.
15. Lee EK, Han JM, Hyon JY, Yu HG. Changes in choroidal thickness afterintravitreal dexamethasone implant injection in retinal vein occlusion.Br J Ophthalmol. 2015;99(11):1543-1549.
16. Esen E, Sizmaz S, Demircan N. Choroıdal thickness changes afterintravitreal dexamethasone implant injection for the treatment ofmacular edema due to retinal vein occlusion. Retina. 2016;36(12):2297-2303.
17. Aribas YK, Hondur AM, Tezel TH. Choroidal vascularity index andchoriocapillary changes in retinal vein occlusions. Graefes Arch ClinExp Ophthalmol. 2020;258(11):2389-2397.
18. Hwang BE, Kim M, Park YH. Role of the choroidal vascularity index inbranch retinal vein occlusion (BRVO) with macular edema. PLoS One.2021;16(10):e0258728.
19. Kinoshita T, Imaizumi H, Shimizu M, et al. Systemic and oculardeterminants of choroidal structures on optical coherence tomographyof eyes with diabetes and diabetic retinopathy. Sci Rep. 2019;9(1):16228.
20. Noma H, Minamoto A, Funatsu H, et al. Intravitreal levels of vascularendothelial growth factor and interleukin-6 are correlated withmacular edema in branch retinal vein occlusion. Graefes Arch Clin ExpOphthalmol. 2006;244(3):309-315.
21. Rayess N, Rahimy E, Ying GS, et al. Baseline choroidal thicknessas a short-term predictor of visual acuity improvement followingantivascular endothelial growth factor therapy in branch retinal veinocclusion. Br J Ophthalmol. 2019;103(1):55-59.
22. Kim KH, Lee DH, Lee JJ, Park SW, Byon IS, Lee JE. Regional choroidalthickness changes in branch retinal vein occlusion with macularedema. Ophthalmologica. 2015;234(2):109-18.
Volume 1, Issue 3, 2024
Page : 35-39
_Footer